These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 1874487

  • 21. Combination low-dose lymphoblastoid interferon and thymosin alpha 1 therapy in the treatment of chronic hepatitis B.
    Rasi G, Mutchnick MG, Di Virgilio D, Sinibaldi-Vallebona P, Pierimarchi P, Colella F, Favalli C, Garaci E.
    J Viral Hepat; 1996 Jul; 3(4):191-6. PubMed ID: 8871880
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Peripheral blood lymphocyte populations in chronic liver disease.
    Thomas HC, Freni M, Sanchez-Tapias J, de Villiers D, Jain S, Sherlock S.
    Clin Exp Immunol; 1976 Nov; 26(2):222-7. PubMed ID: 1086752
    [Abstract] [Full Text] [Related]

  • 24. Transfer factor and hepatitis B: a double blind study.
    Ellis-Pegler R, Sutherland DC, Douglas R, Woodfield DG, Wilson JD.
    Clin Exp Immunol; 1979 May; 36(2):221-6. PubMed ID: 477025
    [Abstract] [Full Text] [Related]

  • 25. The efficacy of thymosin in the treatment of chronic hepatitis B virus infection: a meta-analysis.
    Chan HL, Tang JL, Tam W, Sung JJ.
    Aliment Pharmacol Ther; 2001 Dec; 15(12):1899-905. PubMed ID: 11736720
    [Abstract] [Full Text] [Related]

  • 26. Therapeutic response of chronic active hepatitis B (CAHB) to a new immunomodulator: AM3. Immunohematological effects.
    Villarrubia VG, Valladolid JM, Elorza FL, Sada G, Vilchez JG, Jimenez M, Herrerias JM.
    Immunopharmacol Immunotoxicol; 1992 Dec; 14(1-2):141-64. PubMed ID: 1597653
    [Abstract] [Full Text] [Related]

  • 27. A double-blind, placebo-controlled, pilot trial of thymosin alpha 1 for the treatment of chronic hepatitis C.
    Andreone P, Cursaro C, Gramenzi A, Buzzi A, Covarelli MG, Di Giammarino L, Miniero R, Arienti V, Bernardi M, Gasbarrini G.
    Liver; 1996 Jun; 16(3):207-10. PubMed ID: 8873009
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Thymosin alpha-1.
    Ancell CD, Phipps J, Young L.
    Am J Health Syst Pharm; 2001 May 15; 58(10):879-85; quiz 886-8. PubMed ID: 11381492
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Low thymosin alpha-1 concentrations in patients chronically infected with the hepatitis B virus.
    Sherman KE, Jones CC, Goldstein AL, Naylor PH.
    Viral Immunol; 1991 May 15; 4(3):195-9. PubMed ID: 1810323
    [Abstract] [Full Text] [Related]

  • 35. Interferon-alpha receptor expression and regulation in chronic hepatitis B virus infection.
    Lau JY, Sheron N, Morris AG, Bomford AB, Alexander GJ, Williams R.
    Hepatology; 1991 Feb 15; 13(2):332-8. PubMed ID: 1825307
    [Abstract] [Full Text] [Related]

  • 36. Beta- and gamma-interferon in chronic active hepatitis B. A pilot trial of short-term combination therapy.
    Caselmann WH, Eisenburg J, Hofschneider PH, Koshy R.
    Gastroenterology; 1989 Feb 15; 96(2 Pt 1):449-55. PubMed ID: 2492011
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.